MTOR and gastrointestinal stromal tumor: Novel HSP90 inhibitors, NVP-AUY922 and TAS-116, can downregulate both total and phosphorylated KIT proteins, and mTOR inhibitors can enhance the inhibitory role of NVP-AUY922 in GIST cells [205–207].